Cargando…
Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
OBJECTIVE: Ceramides have been associated with several ageing-related conditions but have not been studied as a general biomarker of multimorbidity (MM). Therefore, we determined whether ceramide levels are associated with the rapid development of MM. DESIGN: Retrospective cohort study. SETTING: May...
Autores principales: | St Sauver, Jennifer L, LeBrasseur, Nathan K, Rocca, Walter A, Olson, Janet E, Bielinski, Suzette J, Sohn, Sunghwan, Weston, Susan A, McGree, Michaela E, Mielke, Michelle M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124265/ https://www.ncbi.nlm.nih.gov/pubmed/37085302 http://dx.doi.org/10.1136/bmjopen-2022-069375 |
Ejemplares similares
-
Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile
por: Olson, Janet E, et al.
Publicado: (2019) -
Inflammatory biomarkers, multi-morbidity, and biologic
aging
por: St. Sauver, Jennifer, et al.
Publicado: (2022) -
Implementing the US Department of Health and Human Services definition of multimorbidity: a comparison between billing codes and medical record review in a population-based sample of persons 40–84 years old
por: St Sauver, Jennifer L, et al.
Publicado: (2021) -
Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol
por: Olson, Janet E., et al.
Publicado: (2017) -
Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank
por: Olson, Janet E., et al.
Publicado: (2018)